Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 2/20 | 0.37 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.36 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.36 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.36 |
| ▸ | PLAU | P00749 | 1/20 | 0.35 |
| ▸ | TOP2A | P11388 | 1/20 | 0.35 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25166626 | 0.86 | HSP90AA1 (0.50) | SMN1; SMN2MEN1KMT2ALMNAHSP90AA1 | |
| SCHEMBL24831524 | 0.86 | PDE4A (0.44) | PIM1CARM1PRMT6PRMT8PLAU | |
| SCHEMBL25166631 | 0.84 | HSD17B10 (0.43) | PIM1CARM1PRMT6PRMT8TOP2A | |
| SCHEMBL24831468 | 0.82 | SRC (0.40) | KAT2BMEN1KMT2AHSP90AA1SIGMAR1 | |
| SCHEMBL24831471 | 0.80 | HSP90AA1 (0.39) | SMN1; SMN2MEN1KMT2ALMNAHSP90AA1 | |
| SCHEMBL25166403 | 0.79 | HSP90AA1 (0.48) | PIM1SMN1; SMN2MEN1KMT2ALMNA | |
| SCHEMBL25166523 | 0.76 | PGK1 (0.40) | SMN1; SMN2LMNA | |
| SCHEMBL24831520 | 0.74 | HSD17B10 (0.43) | MEN1KMT2ALMNA | |
| SCHEMBL25166627 | 0.74 | LMNA (0.53) | SMN1; SMN2MEN1KMT2ALMNAHSP90AA1 | |
| SCHEMBL24831574 | 0.74 | SRC (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230123334-A1 | AMINO LIPID COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | Shenzhen Shenxin Biotechnology Co., Ltd. (CN) | 2023-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230123334-A1 | AMINO LIPID COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | CETP, PLIN1, NOTUM | PIM1 891/4885CARM1 2798/4885PRMT6 790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.